CD8+ TILs

Personalizing the Treatment of Head and Neck Cancer

Screenshot of slide from webinar

Kevin J. Contrera, MD, MPH, Assistant Professor, Department of Otolaryngology-Head & Neck Surgery, opened the Eye & Ear Foundation’s May 6 webinar, “Personalizing the Treatment of Head and Neck Cancer,” […]

Read More… from Personalizing the Treatment of Head and Neck Cancer

Promising Biomarker for Personalizing HNC Care

JCO Precision Oncology cover

CD8+ tumor-infiltrating lymphocytes (TILs) are immune cells that play a key role in the body’s response to cancer. As a result, they have been used across oncology to help assess […]

Read More… from Promising Biomarker for Personalizing HNC Care

Top